The threshold question
10The "reason to believe" threshold question is one that has been described as being "undemanding". Recently, Ward JA cited with approval the observations of Maxwell P and Buchanan JA in Livingspring at [15] as follows:-
"The phrase 'reason to believe' is the touchstone of jurisdiction. It requires a rational basis for the belief - and no more. The wording adopted may be contrasted with other familiar formulations such as 'If the court is satisfied that ...' or 'If in the view of the court it is likely that ...'. The section requires the making of a judgment, a risk assessment: is there a risk that the corporation will be unable to pay? (It adds nothing, in our view, to say that it must be a "real risk".) A risk assessment is, of necessity, imprecise. The section calls for a practical, commonsense approach to the examination of the corporation's financial affairs."
See HP Mercantile Pty Ltd v Dierickx [2013] NSWCA 87 at [7]; see also generally [6] - [9].
11I would respectfully disagree with their Honours' view that it "adds nothing" to say the risk must be a "real" (or "sensible") risk. The matter for consideration is whether there is "reason to believe" the plaintiff will be unable to meet an adverse costs order. There can only be "reason" to have such a belief if the risk facing the applicants for security is more than merely fanciful, or theoretically possible. There must be a sensible basis upon which to conclude the risk exists. There cannot be "reason to believe" merely because there is "a" risk, no matter how slight, that the plaintiff will not be able to meet an adverse costs order.
12Mr Durack SC, who appeared with Mr Keizer for the plaintiff, also drew attention to the observations of Redlich JA in Australia and New Zealand Banking Group Ltd v Oswal [2013] VSCA 156 at [11] and [12] as follows:-
"Costs are usually assessed and payable some considerable time after the Court hands down its decision, giving an unsuccessful party time to liquidate such of its non-current assets as may be required to satisfy an adverse costs order. There is no authority that the respondent to a motion for security for costs must have liquid funds available at the time of the hearing of the motion. Its ability to liquidate it assets by the time any costs may become payable should be taken into account (citing Forster J in Putney Group Pty Ltd v Royal Rehabilitation Centre Sydney [2009] NSWSC 44 at [94]). Although a respondent may not be entitled to 'extended time' to realise assets in order to pay a costs order (citing Brereton J in Street v Luna Park Sydney [2006] NSWSC 1317 at [16]), the discretion must be broad enough to permit a reasonable time in which to do so.
As a matter of principle the discretion to grant or refuse security should not be circumscribed by a requirement that an asset within the jurisdiction be necessarily immediately available and accessible when there is no imminent likelihood that the applicant will obtain a costs order which it will seek to enforce. What is required is that the applicant have ready and certain access to the amount secured if and when entitlement to claim it arises (citing Nicholas J in Ashington Capital Pty Ltd v Parissen Capital (Project X) Pty Ltd [2012] NSWSC 410 at [41])."
13The total amount of security sought by the defendants is in the order of $2 million. The plaintiff disputes, on a number of bases, that the defendants would, together, be entitled to security in this amount. I will, however, approach the threshold question on the basis that, were security to be ordered, it would be in this order.
14The plaintiff is an established business. It has some 150 employees and trades in a field, nuclear medicine, which has high barriers to entry. It has been consistently profitable since 2010 with substantial revenues, sizeable trade debtors and significant net assets.
15The plaintiff's current financial position is set out in its management accounts for the six month period to 30 June 2013.
16The plaintiff's profit and loss statement for the six month period to 30 June 2013 shows gross sales revenue in the order of $13.8 million, costs of goods sold in the order of $9.8 million and gross profit in the order of $4 million. Total operating costs were in the order of $3.7 million, leaving an operating profit of $243,504.97.
17After taking account of "non-operating expenditure" (primarily over $1 million of legal fees arising from this litigation), the plaintiff recorded a loss, after financing expenses, taxation and extraordinary items of a little under $1 million.
18The plaintiff's financial performance is thus characterised by a high turnover, relatively low operating profit and an overall trading loss that is clearly caused by the burden of this litigation.
19However, the plaintiff's balance sheet, as at 30 June 2013, shows an excess of current assets over current liabilities in the order of $1.2 million.
20Certain current liabilities are represented by intercompany loans. In that regard, Mr Durack informed the Court that the ultimate owner of the plaintiff, Mr Bagerdjian, gave the Court the following undertaking: -
"That he will procure that none of HSB Holdings Inc, Global Medical Solutions Limited or any of their subsidiaries require payment of any debt owing to them or which may become owing to them by the plaintiff before judgment in these proceedings or thereafter if a costs order is made in favour of any of the defendants as a part of or consequent upon such judgment without the consent of the defendants or leave of the Court."
21Overall, the plaintiff has an excess of assets over liabilities in the order of $4.4 million (compared to $4 million in 2010, $4.7 million in 2011 and $5.4 million in 2012).
22The plaintiff's principal current assets are debtors in the order of $5.4 million and stock in the order of $1.8 million. So far as debtors are concerned, the audited accounts for the plaintiff for the year ended 31 December 2012 suggest that it has a very low rate of doubtful debts (in the order of 2.2 per cent). So far as stock is concerned, it appears to comprise radiopharmaceuticals which Mr Durack submitted were "readily available to be realised".
23In addition to making submissions arising from the plaintiff's accounts, Mr Durack made submissions concerning what he described as the likely "enterprise value" of the plaintiff.
24Mr Durack pointed to the audited accounts of the plaintiff for the year ended 31 December 2012 that showed a profit of $623,382. Mr Durack submitted that if one added back to that figure depreciation ($899,719) and legal costs associated with these proceedings ($977,379), the resultant "normalised" EBITDA (earnings before interest tax, depreciation and amortisation) would be in the order of $2.5 million.
25Mr Durack submitted that to arrive at an "enterprise value" of the plaintiff, it is necessary to apply a multiple to that normalised EBITDA. Mr Durack submitted that a multiple of seven was appropriate (for reasons I will discuss) and that application of this multiple, and deduction thereafter of borrowings (recorded in the accounts as $3.1 million), resulted in a "very conservative" enterprise value in the order of $14 million.
26The seventh defendant, The Zuellig Group Incorporated ("ZGI"), is the ultimate holding company of the first defendant (Axiom Molecular Pty Ltd - now in liquidation). In 2011, before the events with which these proceedings are concerned, ZGI was contemplating acquiring the business conducted by the plaintiff's parent (Global Medical Services Ltd ("GMSL")) which business included that conducted by the plaintiff. The evidence reveals that ZGI adopted an "exit market multiple" of seven when performing some calculations referrable to its contemplated investment. Mr Durack submitted that the adoption by ZGI of that multiple in those circumstances demonstrated the reasonableness of his adoption of it in the calculations I set out at [25] above.
27Mr Durack submitted that these calculations showed how unlikely it was that those controlling the plaintiff, and its parent, would be prepared to, as it were, "cut the plaintiff adrift" in the event that it was unsuccessful in these proceedings and was ordered to pay the defendants' costs.
28Mr Brereton SC, who appeared with Ms Higgins and Ms Roughley for the third to tenth defendants, and Mr Bova, who appeared for the second defendant, submitted that no weight should be placed on these submissions because, first, the matter was one which ought properly to be the subject of expert opinion, and second, there was an absence of any evidence from the directors of the plaintiff, or its parent, on the subject.
29There is, I accept, weight in these criticisms. Further, Mr Durack's submission did not go directly to the question of whether the plaintiff would be able to pay the defendants' costs, if a costs order were made. Rather, the submission went to the question of whether those controlling the plaintiff would leave the plaintiff unsupported if it were otherwise unable to meet those costs; or, perhaps to the question of whether the plaintiff's enterprise could be sold to a third party in the event that any costs order could not otherwise be satisfied.
30However, overall, I find the submission to be of some assistance in resolving the question before me. It does appear to me to be at least arguable that the plaintiff has a significant "enterprise value" and that factor, when seen in the context of the plaintiff's overall financial position, points against the conclusion that there is reason to believe the plaintiff will not be able to meet an adverse costs order.
31A further factor pointing in the same direction, albeit I accept not decisively, is the current low gearing of the plaintiff. The plaintiff's external borrowings comprise something in the order of 5.4 per cent of its total assets and its long term liabilities comprise something in the order of 23.2 per cent of its total assets. This points to the conclusion that, were it necessary to do so, the plaintiff has ample assets to offer a prospective lender. Of course, one must also consider the plaintiff's capacity to service any increased borrowings.
32Mr Bova pointed to evidence given by the solicitor for the plaintiff in proceedings commenced by GMSL in California (to which I referred in my judgment in these proceedings of [2013] NSWSC 665 at [1]) that GMSL has paid some $639,686 of the plaintiff's fees in these proceedings. Mr Bova submitted that this suggested that the plaintiff was not able to pay its fees in these proceedings from its own resources. I am not prepared to draw any inference adverse to the plaintiff arising out of these circumstances. GMSL has its own interest in the successful prosecution by the plaintiff of these proceedings. It is likely that GMSL is contributing to the plaintiff's legal fees for this reason.
33The plaintiff has significant assets (debtors and stock) that the plaintiff is likely to be able to realise in sufficient time to meet any obligation it has to pay costs. Were an adverse costs order to be made, I see no reason to believe that the plaintiff would not be able to realise its assets in time to satisfy that order.
34It is true that, because of the costs of these proceedings, the plaintiff is trading at a loss. Historically, however, it has been profitable. It has a high turnover and healthy gross profit (albeit a relatively slender operating profit, leaving aside legal costs).
35In all of these circumstances, I see no reason to believe that the plaintiff could not meet an adverse costs order, even if it were to be in the order of $2 million (as the defendants contend). Adopting a "practical, commonsense approach to examination of" the plaintiff's financial position (see [10] above), I do not see that there is a real or sensible risk (see [11] above) that the plaintiff will be unable to meet an adverse costs order.
36Overall, I am not satisfied that the defendants have established the "threshold" question.